JNK modulates RAGE/β-catenin signaling and is essential for allergic airway inflammation in asthma

Guohua Huang,Jinwei Su,Wenqu Zhao,Zhixuan Deng,Ping Wang,Hangming Dong,Haijin Zhao,Shaoxi Cai

DOI: https://doi.org/10.1016/j.toxlet.2020.10.002

IF: 4.271

2021-01-01

Toxicology Letters

Abstract:<p>As a leading cause of occupational asthma, toluene diisocyanate (TDI)-induced asthma is an inflammatory disease of the airways with one of the most significant characteristics involving inflammation, in which the receptor of advanced glycation end products (RAGE) plays an extremely important role. However, the mechanism underlying the upregulation of RAGE is still unknown. The aim of the present study was to examine whether JNK mediates β-catenin stabilization via activation of RAGE in asthma. Herein from the results by analyzing the blood from healthy donors and patients with asthma, it was found that the expression of RAGE and p-JNK is highly correlated and elevated concomitantly with the severity of bronchial asthma. Additionally, upon sensitizing and challenging the mice with TDI, we found that RAGE inhibitor (FPS-ZM1) and JNK inhibitor (SP600125) significantly reduced the TDI-induced asthma inflammation in vivo. Furthermore, SP600125 also considerably restored RAGE and p-JNK expression. Besides, the in vitro results from TDI-HSA treatment of 16HBE cells reveal that therapeutic inhibition of JNK reduced TDI driving RAGE expression and β-catenin translocation, while treatment with Anisomycin, a JNK agonist, showed the opposite effect. Moreover, genetic knockdown of RAGE does not contribute to JNK phosphorylation, indicating that JNK functions upstream of RAGE. Collectively, these findings highlight a role for JNK signaling in RAGE/β-catenin regulation and have important therapeutic implications for the treatment of TDI induced asthma.</p>

toxicology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the role of JNK (c - Jun N - terminal kinase) in asthma (especially TDI - induced asthma) and its relationship with RAGE (receptor for advanced glycation end products) and β - catenin signaling pathways. Specifically, the study aims to answer the following key questions: 1. **Does JNK play an important role in asthma by activating RAGE to mediate the stabilization of β - catenin?** - The study found that the phosphorylated form of JNK, p - JNK, and the expression of RAGE were significantly increased in the airway epithelial cells of asthma patients, and this expression was related to the severity of asthma. 2. **Is the JNK signaling pathway upstream of the RAGE signaling pathway?** - Verified by experiments, the study found that the JNK inhibitor SP600125 could reduce TDI - driven RAGE expression and the nuclear translocation of β - catenin, while the gene knockdown of RAGE did not affect the phosphorylation level of JNK, indicating that JNK is upstream of RAGE. 3. **Can JNK and RAGE inhibitors effectively alleviate TDI - induced asthma inflammation?** - The experimental results showed that using the RAGE inhibitor FPS - ZM1 and the JNK inhibitor SP600125 could both significantly reduce the airway inflammatory response in the mouse asthma model induced by TDI, including reducing airway hyper - responsiveness, serum IgE concentration, the number of cells in bronchoalveolar lavage fluid, and the levels of IL - 4, IL - 5 and IL - 13. 4. **What is the role of the JNK signaling pathway in RAGE/β - catenin regulation and its significance for the treatment of TDI - induced asthma?** - The research results showed that the JNK signaling pathway plays an important role in RAGE/β - catenin regulation, and this finding provides a new potential target for the treatment of TDI - induced asthma. In summary, through a series of in vivo and in vitro experiments, this paper reveals the key role of the JNK signaling pathway in TDI - induced asthma and proposes the possibility of JNK as a potential treatment target. These findings not only enhance the understanding of the pathological mechanism of asthma but also provide a theoretical basis for the development of new anti - asthma drugs.

JNK modulates RAGE/β-catenin signaling and is essential for allergic airway inflammation in asthma

RAGE mediates airway inflammation via the HDAC1 pathway in a toluene diisocyanate-induced murine asthma model

TLR2 Promotes Allergic Airway Inflammation Through JNK Signaling Pathway with Activation of Autophagy

Srage Alleviates Neutrophilic Asthma by Blocking HMGB1/RAGE Signalling in Airway Dendritic Cells

Bongkrekic acid alleviates airway inflammation via breaking the mPTP/mtDAMPs/RAGE feedback loop in a steroid-insensitive asthma model

HMGB1/RAGE Signaling Regulates Th17/IL-17 and Its Role in Bronchial Epithelial-Mesenchymal Transformation

[Expression of RAGE in Asthmatic Rats and the Intervention of Roxithromycin].

Toluene diisocyanate-induced inflammation and airway remodeling involves autophagy in human bronchial epithelial cells

Inhibition of P21-Activated Kinase 1 Attenuates the Cardinal Features of Asthma Through Suppressing the Lymph Node Homing of Dendritic Cells.

RGS4 controls airway hyperresponsiveness through GAP-independent mechanisms

Heme oxygenase-1 alleviates allergic airway inflammation by suppressing NF-κB-mediated pyroptosis of bronchial epithelial cells

PTRF-IL33-ZBP1 signaling mediating macrophage necroptosis contributes to HDM-induced airway inflammation

Bergenin ameliorates airway inflammation and remodeling in asthma by activating SIRT1 in macrophages to regulate the NF-κB pathway

Endothelin-1-mediated Brainstem Glial Activation Produces Asthmatic Airway Vagal Hypertonia Via Enhanced ATP-P2X4 Receptor Signaling in Sprague–Dawley Rats

Mediation of the JNC/ILC2 pathway in DBP-exacerbated allergic asthma: A molecular toxicological study on neuroimmune positive feedback mechanism

Jolkinolide B attenuates allergic airway inflammation and airway remodeling in asthmatic mice

LRRK2 G2019S enhances immune response pathways and aggravates asthma in mouse models

RAGE and TLR4 differentially regulate airway hyperresponsiveness: Implications for COPD

Lipopolysaccharides induce a RAGE-mediated sensitization of sensory neurons and fluid hypersecretion in the upper airways

Transcriptomics reveals apigenin alleviates airway inflammation and epithelial cell apoptosis in allergic asthma via MAPK pathway

Prevention of IL-6 signaling ameliorates toluene diisocyanate-induced steroid-resistant asthma